Scientific Advisory Board
Meet our board of scientific advisors.
Gregory Poland, Chair
Dr. Gregory Poland is the Director of Mayo Clinic’s Vaccine Research Group – a state-of-the-art research group and laboratory that investigates issues surrounding vaccine response, vaccine policy, and novel vaccines. Dr. Poland is the Mary Lowell Leary Professor of Medicine and Infectious Diseases, the Director of the Immunization Clinic and the Director of the Program in Translational Immunovirology and Biodefense at the Mayo Clinic. He is the Editor-in-Chief for the journal VACCINE.
Additionally, Dr. Poland participates on many national and academic review committees and actively peer-reviews journal articles for over 26 different scientific and medical journals. A prolific writer, Dr. Poland has published more than 400 peer-reviewed scientific articles and book chapters such as The Lancet, Annals of Internal Medicine, and New England Journal of Medicine.
Dr. Poland’s laboratory examines the immunogenetic drivers of viral vaccine response. He currently holds 5 federal grants dealing with the immunogenetics of smallpox, measles, rubella, and influenza vaccine responses. Dr. Poland developed the immune response network theory, and invented the field of vaccinomics and personalized vaccinology.
Richard Bianco is Director of Experimental Surgery and Associate Professor of Surgery at the University of Minnesota. He has 30+ years of experience in the management of Experimental Surgical projects and has authored numerous refereed journal articles and book chapters on the topics of animal model development and testing of medical devices with a major emphasis in the area of cardiovascular prostheses. Professor Bianco serves as co-chair of the AAMI/VP vascular prostheses committee and as a member of the International Standards Organization Cardiovascular Implants and Extracorporeal Systems Committee, Vascular Prostheses Working Group.
Richard W. Bianco served as Associate Vice President for Research at the University of Minnesota from 2006 – 2007 and is a primary architect of the integrated compliance program at the University of Minnesota. In this capacity he oversaw research compliance, including the Research Subjects Protection Program (administrative home of the IRB and IACUC.), served as the Institutional Official for Human Subjects Protection and the Animal Care Program and directed the conflict of interest management program for the University of Minnesota.
Paul Citron retired in 2003 after 32 years with Medtronic, Inc. His positions included vice president, Technology Policy and Academic Relations (2002-2003); vice president, Science and Technology (1988-2002); vice president, Ventures Technology (1985-1988); vice president, Applied Concepts Research (1982-1985); director, Applied Concepts Research (1979-1982); and several positions as design and staff engineer, project and program manager (1972-1979). In addition, he worked with leading biomedical engineering institutions including Johns Hopkins University, MIT, University of Minnesota, Georgia Tech, and Case Western Reserve. In 1980, Mr. Citron was given Medtronic’s “Invention of Distinction” award for his role as co-inventor of the tined pacing lead, a technology that markedly improved the reliability and effectiveness of cardiac pacing. In addition, he has several other medical pacing-related device patents. Currently he is adjunct professor at the University of California, San Diego, Jacobs School of Engineering. He is also a consultant to biomedical start-up companies and venture capital firms. Mr. Citron earned a B. S. in electrical engineering from Drexel University in 1969 and a M. S. in electrical engineering from the University of Minnesota in 1972, where he was a research fellow in the Department of Neurology. Mr. Citron’s professional honors include his election to the National Academy of Engineering in 2003, and he was elected a Founding Fellow of the American Institute of Medical and Biological Engineering in 1993. He has twice won the American College of Cardiology Governor’s Award for Excellence. In 1980 Citron was inducted as a Fellow of Medtronic’s Bakken Society, the company’s highest technical recognition. He was voted the Institute of Electrical and Electronic Engineering’s Young Electrical Engineer of the Year in 1979. Citron has published widely on biomedical engineering. Citron has served and continues to serve on numerous professional advisory boards and committees including the Institute of Medicine, National Academy of Engineering, and National Research Council.
Peter Ernst, DVM, PhD, is a Professor and head of the Division of Comparative Pathology and Medicine in the Department of Pathology at UCSD and the co-Director of the University of California Veterinary Medical Center – San Diego. He formed, and directs the Center for Veterinary Sciences and Comparative Medicine at UCSD which has the goal of developing collaborative research opportunities and post-graduate training programs for veterinarians. Before coming to UCSD, he was on faculty at McMaster University in Canada, the University of Texas Medical Branch in Galveston and the University of Virginia. He currently serves on the advisory boards for Antibe Therapeutics and the Institute of Infection and Immunity in the Canadian Institutes of Health Research. Dr. Ernst’s research interests are in mucosal immunology and the control of gastrointestinal responses to bacterial infection. These topics are studied in the context of food- and water-borne illness and the bacterial triggers of chronic inflammation in the stomach and intestine using both human tissue and animal models of human disease.
Gregory C. Gray
Professor Gregory C. Gray MD, MPH, FIDSA is a Professor and Chair of the Department of Environmental and Global Health in the University of Florida’s College of Public Health and Health Professions. He directs the Global Pathogens Laboratory in the University of Florida’s Emerging Pathogens Institute. He has a joint appointment in the University of Florida’s College of Veterinary Medicine.
He received his MD from the University of Alabama at Birmingham, and his MPH from Johns Hopkins School of Hygiene & Public Health. His medical boards are in Preventive Medicine and Public Health.
He has conducted epidemiological infectious disease research for 25 years in the United States and abroad. In 2010 he was recruited to his present position at the University of Florida. His current research interests include studying animal workers for evidence of occupational infections with zoonotic pathogens, especially respiratory viruses. He leads his Global Pathogens Laboratory team and international collaborators is studying persons with occupational exposure to camels, cattle, ducks, dogs, geese, goats, marine mammals, pigs, and poultry in a number of countries including Bangladesh, Cambodia, Georgia, Kenya, Madagascar, Mongolia, Romania, Thailand, and the United States.
A strong proponent of the One Health Initiative, his department has the only Masters and PhD One Health concentration degree programs in the United States. He has authored more than 190 publications in the peer-reviewed medical literature. Currently, he serves as a member of the FDA’s Vaccines and Related Biological Products Advisory Committee, an Associate Editor for the journal Infection and Public Health and on the Editorial Board for the journal Influenza and Other Respiratory Viruses. He also serves on the Institute of Medicine’s Board on the Health of Select Populations.
Frances M. D. Gulland
Frances Gulland is the Senior Scientist at The Marine Mammal Center in Sausalito, California. She has been actively involved in the veterinary care and rehabilitation of stranded marine mammals and research into marine mammal diseases there since 1994. Her interests include determining the impacts of human activities on marine mammal health, and how marine mammals can in turn serve as indicators of ocean health. She received a veterinary degree from the University of Cambridge, UK, in 1984, and a PhD in Zoology there in 1991. Before moving to California in 1994, she worked as a veterinarian at the London Zoo in Regents Park, London, then as a researcher in the Serengeti. She currently serves as Commissioner on the U. S. Marine Mammal Commission.
Marc Montminy, M.D., Ph.D., professor in the Clayton Foundation Laboratories for Peptide Biology, joined The Salk Institute in 1999. Dr. Montminy conducts research on the genetic basis of diabetes, including the control of glucose homeostasis during fasting. His laboratory’s research may offer therapeutic benefit to individuals with type II diabetes. Dr. Montminy received a combined M.D./Ph.D. in physiology from the Tufts University School of Medicine and a B.S. in biochemistry from Harvard College. Prior to joining Salk, Montminy was a professor of cell biology at Harvard Medical School and director of the Laboratory of Advanced Genetic Technologies and section head of Molecular Biology at Joslin Diabetes Center in Boston. He has published numerous scientific studies throughout his career in the nation’s top scientific journals, Nature, Science, and PNAS. Dr. Montminy is a member of the National Academy of Sciences (USA).
David A. Relman, M.D., is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine, and of Microbiology and Immunology at Stanford University, and Chief of Infectious Diseases at the VA Palo Alto Health Care System in Palo Alto, California. He received an S.B. (Biology) from MIT (1977), M.D. (magna cum laude) from Harvard Medical School (1982). During the past few decades, his research directions have included pathogen discovery and the development of new strategies for identifying previously-unrecognized microbial agents of disease. Dr. Relman advises the U.S. Government, as well as non-governmental organizations, in matters pertaining to microbiology, emerging infectious diseases, and biosecurity. He currently serves as Chair of the Institute of Medicine’s Forum on Microbial Threats (U.S. National Academies of Science), as a member of the National Science Advisory Board for Biosecurity, a member of the Physical and Life Sciences Directorate Review Committee for Lawrence Livermore National Laboratory, and advises several U.S. Government departments and agencies on matters related to pathogen diversity, the future life sciences landscape, and the nature of present and future biological threats. He is currently (2010-2011), Vice-President of the Infectious Diseases Society of America (IDSA). Dr. Relman served as vice-chair of a National Academies of Sciences study of the science underlying the FBI investigation of the 2001 anthrax mailings, and co-chaired a three-year NAS study that produced a widely-cited report entitled, “Globalization, Biosecurity, and the Future of the Life Sciences” (2006). He is a Fellow of the American Academy of Microbiology, a Fellow of the AAAS, and a member of the Association of American Physicians. Dr. Relman received the Squibb Award from the IDSA in 2001, and was the recipient of both the NIH Director’s Pioneer Award, and the Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation, in 2006.
Carol Rubin, DVM, MPH, is Associate Director for Zoonoses and One Health in the National Center for Emerging Zoonotic and Infectious Diseases (NCEZID) and is embedded in the Division of High-Consequence Pathogens and Pathology as Director of the division’s One Health Office at the Centers for Disease Control and Prevention (CDC). Dr. Rubin came to CDC in 1990 as an Epidemic Intelligence Service Officer (EIS) and subsequently completed a Preventive Medicine Residency and held positions as an epidemiologist and Branch Chief. Dr. Rubin has published more than 80 articles in peer-reviewed journals and led numerous national and international investigations and outbreak responses on behalf of CDC. She currently serves on the American Veterinary Medical Association (AVMA) Committee on Disaster and Emergency Issues and is the CDC representative on the Advisory Panel to the AVMA House of Delegates. Prior to coming to CDC she spent almost a decade in private veterinary practice.